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ﻊﺳﺍﻭﻕﺎﻄﻧﻰﻠﻋﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﺃﻒﺻﻮﺗ:ﺚﺤﺒﻟﺍﻑﺍﺪﻫﺃ
ﺔﻳﺮﻳﺮﺴﻟﺍﺔﺑﺎﺠﺘﺳﻻﺍﺪﻤﺘﻌﺗ.ﻦﻣﺰﻤﻟﺍﻱﻮﺋﺮﻟﺍﺩﺍﺪﺴﻧﻻﺍﻰﺿﺮﻣﻭﻮﺑﺮﻟﺍﻰﺿﺮﻤﻟ
ﺔﺤﻴﺤﺼﻟﺍﺮﻴﻏﺔﻘﻳﺮﻄﻟﺍﻊﻨﻤﺗ.ﺾﻳﺮﻤﻟﺍﻕﺎﺸﻨﺘﺳﺍﺔﻘﻳﺮﻃﻰﻠﻋﺔﻘﺸﻨﺘﺴﻤﻟﺍﺔﻳﻭﺩﻸﻟ
ﻲﻓﺓﺭﺎﻬﻤﻟﺍﺔﻳﺎﻔﻛﻡﺪﻋﻖﻴﺛﻮﺗﻢﺗﺪﻗﻭ.ﺔﻳﻭﺩﻷﺍﻦﻣﻯﻮﺼﻘﻟﺍﺓﺩﺎﻔﺘﺳﻻﺍﻦﻣﻰﺿﺮﻤﻟﺍ
ﻖﻘﺤﺘﻟﺍﻰﻟﺇﺔﺳﺍﺭﺪﻟﺍﻩﺬﻫﻑﺪﻬﺗ.ﺍﺪﻴﺟﺔﻟﺩﺎﻴﺼﻟﺍﻞﺒﻗﻦﻣﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﺃﻡﺍﺪﺨﺘﺳﺍ
ﻦﻴﺑﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﻷﺢﻴﺤﺼﻟﺍﻡﺍﺪﺨﺘﺳﻻﺍﻭﺔﻤﺋﻼﻤﻟﺍﻯﺪﻣﻦﻣ
.ﻦﻤﻴﻟﺎﺑﺀﺎﻌﻨﺻﻲﻓﻊﻤﺘﺠﻤﻟﺍﺕﺎﻴﻟﺪﻴﺻﻲﻓﺔﻟﺪﻴﺼﻟﺍﻲﻴﻨﻓﻭﺔﻟﺩﺎﻴﺼﻟﺍ
ﻊﻤﺘﺠﻤﻟﺍﺕﺎﻴﻟﺪﻴﺻﻲﻓﻦﻴﻠﻣﺎﻌﻟﺍﻦﻴﺑﺔﻴﻌﻄﻘﻣﺔﺳﺍﺭﺩﻞﻤﻋﻢﺗ:ﺚﺤﺒﻟﺍﻕﺮﻃ
ﻮﻴﻟﻮﻳ١ﻦﻣﺓﺮﺘﻔﻟﺍﻲﻓ٬ﻦﻤﻴﻟﺎﺑﺀﺎﻌﻨﺻﺔﻤﺻﺎﻌﻟﺍﻲﻓ(ﺔﻟﺪﻴﺻﻲﻴﻨﻓﻭﺔﻟﺩﺎﻴﺻ)
ﻦﻣﻖﻘﺤﺘﻠﻟﺾﻳﺮﻤﻟﺍﺓﺎﻛﺎﺤﻣﺞﻬﻧﻡﺍﺪﺨﺘﺳﺎﺑ.ﻡ١١٠٢ﺲﻄﺴﻏﺃ٦٢ﻰﻟﺇﻡ١١٠٢
.ﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﻷﺢﻴﺤﺼﻟﺍﻡﺍﺪﺨﺘﺳﻻﺍ
ﻭﺔﻟﺩﺎﻴﺼﻟﺍﻦﻣﺍﻮﻧﺎﻛ(٪٢٬٤١)٣٣٬ﺔﺳﺍﺭﺪﻟﺍﻲﻓﺎﻛﺭﺎﺸﻣ٢٣٢ﻞﺻﺃﻦﻣ:ﺞﺋﺎﺘﻨﻟﺍ
ﻲﻴﻨﻓﻭﺔﻟﺩﺎﻴﺼﻟﺍﻦﻴﺑﺮﻴﺒﻛﻑﻼﺘﺧﺍﻙﺎﻨﻫﻥﺎﻛﻭ.ﺔﻟﺪﻴﺼﻟﺍﻲﻴﻨﻓﻦﻣ(٪٨٬٥٨)٩٩١
.ﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﻷﺢﻴﺤﺼﻟﺍﻡﺍﺪﺨﺘﺳﻼﻟﺔﻓﺮﻌﻤﻟﺍﺚﻴﺣﻦﻣﺔﻟﺪﻴﺼﻟﺍ
ﺔﻟﺩﺎﻴﺼﻟﺍﻒﺼﻧﻯﺪﻟﻥﺎﻛﻯﺮﺧﺃﺔﻴﺣﺎﻧﻦﻣ.ﺔﻓﺮﻌﻤﻟﺍﻲﻠﻴﻠﻗﻡﺎﻋﻞﻜﺸﺑﺔﻟﺪﻴﺼﻟﺍﻲﻴﻨﻓﻥﺎﻛ
ﺓﺮﺒﺨﻟﺍﺐﻌﻠﺗ.ﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﻷﺢﻴﺤﺼﻟﺍﻡﺍﺪﺨﺘﺳﻼﻟﺔﻟﻮﺒﻘﻣﺕﺎﻣﻮﻠﻌﻣ
.ﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﻷﺢﻴﺤﺼﻟﺍﻡﺍﺪﺨﺘﺳﻻﺍﻲﻓﺎﻴﺳﺎﺳﺃﺍﺭﻭﺩﺮﻤﻌﻟﺍﻭ
ﻡﺍﺪﺨﺘﺳﻼﻟﺔﻔﻴﻌﺿﺕﺍﺭﺎﻬﻣﻊﻤﺘﺠﻤﻟﺍﺕﺎﻴﻟﺪﻴﺼﺑﻦﻴﻠﻣﺎﻌﻟﺍﺔﻴﺒﻟﺎﻏﻯﺪﻟ:ﺕﺎﺟﺎﺘﻨﺘﺳﻻﺍ
ﻰﻟﺇﺔﺟﺎﺤﻟﺎﺑﺔﺳﺍﺭﺪﻟﺍﻩﺬﻫﻲﺻﻮﺗﻭ.ﺔﻨﻨﻘﻤﻟﺍﺕﺎﻋﺮﺠﻟﺎﺑﻕﺎﺸﻨﺘﺳﻻﺍﺓﺰﻬﺟﻷﺢﻴﺤﺼﻟﺍ
.ﺔﻳﺩﺎﺷﺭﻻﺍﻢﻬﺗﺍﺭﺎﻬﻣﻦﻴﺴﺤﺘﻟﻊﻤﺘﺠﻤﻟﺍﺔﻟﺩﺎﻴﺻﻦﻴﺑﺔﻴﻠﺧﺍﺪﺗﺔﻴﻤﻴﻠﻌﺗﺞﻣﺍﺮﺑ
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Objectives: Metered Dose Inhalers (MDI) are widely
prescribed for patients with asthma and Chronic
jObstructive Pulmonary Disease (COPD). Clinical
response to inhaled medication depends on the inhalation
technique of the patient. Incorrect technique prevents
patients from getting the maximal benefit from their
medicines. Inadequate skill in the use of inhalation de-
vices by pharmacists has been well documented. The
current study aims to investigate the appropriateness and
correct use of MDIs use among community pharmacists
and pharmacy technicians in community pharmacies in
Sana’a Yemen.
Methods: A cross-sectional study was done among the
community pharmacies dispensers (pharmacists and
pharmacy technicians) in the capital city of Sana’a
Yemen, during the period from 1st July 2011 to 26th
August 2011. A Simulated Patient (SM) approach was
used to investigate the appropriate use of MDIs.
Results: Out of 232 participants included in the analysis, 33
(14.2%) were pharmacists and 199 (85.8%) were pharmacy
technicians. There was significant difference between the
pharmacists and pharmacy technicians in terms of their
knowledge of MDI appropriate use (p-value ¼ 0.000).
Generally pharmacy technicians had a poor knowledge. On
other hand half of pharmacists had a reasonable knowledge
of appropriate use of MDI. Experience and age play major
role in the appropriate use of MDI.
Conclusion: Majority of community pharmacies dis-
pensers have a poor skills of MDI appropriate use. The
results of this study recommend the need for interven-
tional educational programs among community phar-
macists to improve their counselling skills.his is an open access article under the CC BY-NC-ND license
16/j.jtumed.2014.10.002
Y.M. Ali Al-Worafi354Keywords: Community pharmacy; MDI; Pharmacists; Phar-
macy technicians; Yemen
 2015 The Author.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Inhalation medications are widely prescribed for patients
with asthma and chronic obstructive pulmonary disease
(COPD). The inhaled route allows therapeutic agents are
delivered directly to the lungs which provide a more rapid
onset of action, better efficacy and less adverse effects.1,2
Clinical response to inhaled medication depends on the
inhalation technique of the patient. Incorrect technique
prevents patients from getting the maximal benefit from
their medicines.3e5 The most commonly prescribed inhaler
devices are either the metered-dose inhalers (MDIs) and
dry-powder inhalers (DPIs) and the selection should be
based on the: availability, cost, patient preference, physician
preference and clinical situation.6
To use inhalers correctly by the patients with asthma and
COPD they should receive clear instructions and physical
demonstration given by a health professional.7 Patient
education about inhaler technique is very important in the
management of asthma and COPD and can be improved
with education.8,9 The role of the community pharmacist
world wide changes and moved towards a focus on patient
care. The community pharmacist’s should focus more on
patient-oriented services rather than the traditional focus
on product and dispensing services.10 Community
pharmacists can provide effective training in correct inhaler
technique.11
Respiratory diseases including asthma and COPD among
the top 10 causes of morbidity and mortality in Yemen.12
Community pharmacies in Yemen are the most accessible
healthcare facilities to the patients which provide a timely
opportunity to instruct patients on the use and administra-
tion of inhaled medications.13 Community pharmacists can
make a significant contribution to improve the outcome of
treating asthma and COPD patients due to their expertise
on medication and their everyday contacts with the
patients on dispensing and counseling. Pharmacists can
help asthma, COPD patients to achieve the treatment
outcomes by providing the patients with suitable
information and counseling. One of the counseling issues is
educate the patients how they can use their inhaler
medications correctly.
Simulated patient methodology has been adapted and
used to assess quality practice in the health sector as well as in
pharmacy practice.14,15 The use of simulated patients in
pharmacy practice research has become increasingly
worldwide over the past two decades.16e19 There are
different names of simulated patient such as: pseudo
patient, pseudo patron, simulated patient, pseudo
customer, shopper patient or mystery shopper). Simulated
patient is a person who is trained to go to the pharmacywith determined scenarios to assess quality of certain
services provided by pharmacy employees.18e20
Few studies conducting on the Arabic region to investi-
gate the appropriateness of MDIs use among community
pharmacies staff,16 none of these studies conducted in
Yemen. Therefore, the current study aims to compare the
appropriateness (Correct use) of MDIs use among
community pharmacy dispensers in community pharmacies
in Sana’a, Yemen and to investigate factors affecting
appropriateness of MDIs use.
Materials and Methods
A cross-sectional study was done among the community
pharmacies dispensers (Pharmacists and Pharmacy Tech-
nicians) in the capital Sana’a, Yemen. The period of this
study was from 1st July 2011 to 26th August 2011. A
simulated patient approach was to investigate the appro-
priateness of MDIs use among community pharmacists and
pharmacy technicians in community pharmacies in Sana’a,
Yemen.
This study was approved from college of pharmacy,
Qassim University and form the managers of community
pharmacies. No personal data about pharmacies or phar-
macists was obtained. All pharmacy mangers were informed
before the study about the objectives and the confidentiality
of the data. They informed that a simulated patient would
visit their pharmacy for counseling. No details about the type
of counseling were provided. Time of visit was not informed.
Demographic data was collected from the pharmacy man-
agers. The MDI used in this study was Ventolin (Salbuta-
mol) evohealer. The appropriateness of MDI use defined in
this study as correct use of MDIs.
Sample size
According to the annual reports of the Ministry of Public
Health and Population 2010 the numbers of pharmacies are
1138 community pharmacies in the capital Sana’a.21 The
sample size calculation was done by using Raosoft method
Convenient sampling technique was used in this study.
Based on this reports 300 community pharmacies were
selected conveniently to have an estimate of precision at
the 95% confidence interval (CI), with an a ¼ 0.05.
Simulated patient and scenario
Simulated patient methodology was used in this study as
shown in Table 1.
A simulated patient team was consisted of three regis-
tered pharmacists. Furthermore theoretical and practical
workshops about simulation scenario, evaluate MDI
appropriate use and recording method were provided. All
simulated patients underwent MDI use assessment after
workshop. The simulated scenario was that a patient
diagnosed with asthma and went to the community phar-
macy with Ventolin (Salbutamol) evohealer and told the
pharmacy dispenser “My physician has prescribed this
devise for me. Could you please educate me how can I use
it?” The interaction between community pharmacists or
pharmacy technicians and simulated patient was audio
Table 1: Simulated patient methodology.
N Notes
1 Select the simulated patients (SM) Invite and interview registered pharmacists
with minimum 3 years experience. Select 3
registered pharmacists.
2 Train the SM about MDI use, scenario, how to evaluate community
pharmacy dispensers and record the interaction with pharmacy staff
Workshops and educational materials
(Videos, notes and pictures)
3 Examine the ability of SM (MDI use, scenario, how to evaluate
community pharmacy dispensers and audio visually record the
interaction with pharmacy dispensers)
Author and invited external examiners.
4 Conduct study and report results to author
5 Analyze results. Check the reliability of the result by
comparing the SM evaluation checklist
with the recorded video.
6 Sent feedback to community pharmacies A 30 min meeting with community
pharmacists and pharmacy technicians
to increase the awareness of the new
roles of pharmacists and pharmaceutical
care services was done.
Educational materials (Video and
brochures) about MDI appropriate
use was given.
Appropriateness of MDI use in Yemeni community pharmacies 355visually recorded using hidden micro camera and reported
the evaluation using evaluation checklist after leaving the
pharmacy. Furthermore the reliability of the results was
done by comparing the SM evaluation checklist with the
recorded video.Table 2: Recommended checklist of metered-dose inhaler
(MDI).22
Step Score
1 Shake the inhaler wella
2 Remove the dust capa
3 Exhale slowly through pursed lips
4 If using the “closed-mouth” technique,
hold the inhaler upright and place the
mouthpiece between your lips. Be
careful not to block the opening with
your tongue or teeth
If using the “open-mouth” technique,
open your mouth wide and hold the
inhaler upright 1e2 inches from your
mouth, making sure the inhaler is
properly aimed
5 Press down on the inhaler once as you
start a slow, deep inhalationa
6 Continue to inhale slowly and deeply
through your mouth. Try to inhaleEvaluation of the pharmacy staff knowledge about
appropriate use of MDIs
The evaluation was done by using MDI evaluation
checklist as shown in Table 2.
The checklist was adapted from the latest Guidelines for
the Diagnosis and Management of Asthma, National
Asthma Education and Prevention Program.22 Scoring
system was used in this study as each performed step was
given a value of one and unperformed or wrong step was
given a value of zero. A good appropriateness of Ventolin
(Salbutamol) evohealer use is awarded to pharmacists or
pharmacy technician completing successfully seven steps or
more including the critical steps. A moderate
appropriateness of Ventolin (Salbutamol) evohealer use is
awarded to pharmacists or pharmacy technician
completing successfully five or six steps including the
critical steps. A poor appropriateness of Ventolin
(Salbutamol) evohealer use is awarded to pharmacists or
pharmacy technician completing less than or equal to four
steps.for at least 5 s.
7 Hold your breath for 10 s (use your
fingers to count to 10 slowly). If 10
s makes you feel uncomfortable, try
to hold your breath for at least 4 s.
8 Exhale slowly.
9 Wait at least 30e60 s before inhaling
the next puff of medicine.
a Critical step.Statistical analysis
The data were descriptively analyzed using Statistical
Package for the Social Sciences (SPSS) version 15 for
Windows. Differences in proportional were tested with Chi-
square test or Fisher’s Exact test. All reported p-values are
two tailed, and the result is significant if p-value is 0.05.Results
Among 300 community pharmacies approached, 68
pharmacies were excluded from the study because of: the
unclear video recorded or asked the simulation patient (SP)
to read leaflet or refer SP to hospital to see the physician. Out
Table 3: Metered-dose inhaler (MDI) appropriate use.
Step Pharmacists.
33 (100%)
Pharmacy
technicians.
199 (100%)
p-Valuea
1 Shake the inhaler wellb 17 (51.5) 23 (11.6) 0.000
2 Remove the dust capb 33 (100) 154 (77.4) 0.001
3 Exhale slowly through pursed lips. 17 (51.5) 3 (1.5) 0.000
4 If using the “closed-mouth” technique, hold the inhaler upright and place the mouthpiece
between your lips. Be careful not to block the opening with your tongue or teeth.
17 (51.5) 56 (28.1) 0.014
If using the “open-mouth” technique, open your mouth wide and hold the inhaler upright
1e2 inches from your mouth, making sure the inhaler is properly aimed.
5 Press down on the inhaler once as you start a slow, deep inhalationb 17 (51.5) 0 (0) 0.000
6 Continue to inhale slowly and deeply through your mouth. Try to inhale for at least 5 s. 15 (45.5) 0 (0) 0.000
7 Hold your breath for 10 s (use your fingers to count to 10 slowly). If 10 s makes you feel
uncomfortable, try to hold your breath for at least 4 s.
9 (27.3) 0.000 0.000
8 Exhale slowly. 15 (45.5) 0 (0) 0.000
9 Wait at least 30e60 s before inhaling the next puff of medicine. 9 (27.3) 0.000 0.000
a Chi-square test or Fisher’s Exact test.
b Critical step.
Y.M. Ali Al-Worafi356of 232 pharmacies, 33 (14.2%) were pharmacists and 199
(85.8%) were pharmacy technicians. 225 (97%) were male
and 7 (3%) were females. The mean age of the respondents
was found to be 25.60  3.278 years. 69.4% of the re-
spondents age were 25 years old. Among the respondents
89 (38.4%) had an experience more than three years and the
rest had a 3 year experience or less.
Table 3 shows the comparison between pharmacists and
pharmacy technicians in terms of MDI appropriate use.
Table 4 shows the factors affecting MDI appropriate use.
Discussion
The findings of this study shows that the majority of re-
spondents were pharmacy technicians (85.8%), this is
consistent with the previous report that majority of the
pharmacy dispensers in Yemen were non pharmacist.13 Hire
a qualified pharmacists is needed to improve the counseling
provided in the community pharmacies in Yemen.Table 4: Factors affecting MDI appropriate use.
Characteristics Total Good knowledge
(Appropriate use)
p-Valuea
n (%) 232 (100%) 15 (6.5%)
Education
Pharmacist 33 (14.2) 15 (100) 0.000
Pharmacy
technician
199 (85.8) 0 (0)
Experience
>3 years 89 (38.4.) 10 (66.7) 0.021
3 years 143 (61.6) 5 (33.3)
Gender
Male 225 (97) 15 (100) 1.000
Female 7 (3.0) 0 (0)
Age
>25 years old 71 (30.6) 10 (66.7) 0.003
25 years old 161 (69.4) 5 (33.3)
a Chi-square test or Fisher’s Exact test.The findings of this study shows that the males percentage
were (97%), this is similar to the previous reports.23e25 This
study showed that there was significant difference (p-
value ¼ 0.000) between the pharmacists and pharmacy
technicians in terms of their knowledge of MDI
appropriate use. Pharmacy technicians have a poor
knowledge. The most common problems among pharmacy
technicians with MDI use were step 5, 6, 7, 8 and 9. On
other hand half of pharmacists had a good knowledge of
MDI appropriate use.
The findings of this study shows that experience and age
play a major role on MDI appropriate use. There was sig-
nificant difference between pharmacists with experience
more than three years and pharmacists with three year
experience or less (p-value ¼ 0.021).
Generally this study has found that majority of commu-
nity pharmacy dispensers (93.5%) had poor knowledge and
unfamiliar with MDI appropriate use. This findings is
consistent with studies in Arabic countries.16 MDIs are
usually prescribed to patients with asthma and COPD and
the success of the therapy depends on correct inhaler
technique use.1e5 The improper inhaler technique use will
lead to uncontrolled diseases, worsening treating outcomes,
increase emergency departments visits and decrease quality
of life. Educate the patients on the correct MDI technique
improve their device use and control the disease.
Pharmacist counselling can significantly improve MDI
technique. Community pharmacies in Yemen are
considered a valuable and easy resource for patients for
treatment and counselling.13
Development in Pharmacy practice since last decades
especially after the introduction of clinical pharmacy con-
cepts in the late 1960s, followed by the philosophy of phar-
maceutical care in the early 1990s has contributed very much
in the public health, improve treatment outcomes and
improve quality of life. Pharmaceutical care changed the
approach of Pharmacy practice from product oriented to
Patient oriented.26,27
Community pharmacists in Yemen can be trained easily
for providing pharmaceutical care to patients. Training
Appropriateness of MDI use in Yemeni community pharmacies 357provided to community pharmacists has a positive effect on
their knowledge and skills and can improve patient drug
knowledge, inhaler technique, and level of compliance. Ac-
cording to the conducted international studies about the
impact of providing pharmaceutical care by pharmacists for
patients with asthma and COPD, pharmacists not only
improved patients’ inhalers technique use but medications
knowledge, and adherence therapy. Which leads to improve
treating outcomes, control their diseases and improve patient
quality of life.28e31 The feedback was given to community
pharmacists and pharmacy technicians. Educational
materials (Videos and brochures) about MDI appropriate
use was given to community pharmacists and pharmacy
technicians. A 30 min meeting with community
pharmacists and pharmacy technicians to increase the
awareness of the new roles of pharmacists and
pharmaceutical care services was done.
Conclusion
Majority (85.8%) of Pharmacy dispensers in this study
were pharmacy technicians and they were not aware of MDI
appropriate use. Half of the community pharmacists in
community pharmacies had a poor knowledge of MDI.
Experience play important role on MDI appropriate use
among community pharmacists. Educational materials was
given to community pharmacists and pharmacy technicians.
It may contribute to improve their skills on MDI technique
and educate patients correctly on their MDIs.
This study was done only on the capital Sana’a. We can’t
generalize the result of this study. Studies on other cities are
highly recommended. Increase the awareness towards the
important of counselling and move towards provide a good
pharmaceutical care are highly recommended. Study of the
impact of different interventions to improve inhaler tech-
nique are highly recommended.
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